Who invested in BioTime?
BioTime's investors include Juvenescence.
United States · Funded startup
9 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$107Mraised across 9 rounds since 2009, from 9 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
No investor was named in the report.
From a historical funding record
No investor was named in the report.
From a historical funding recordSEC filing: $3.5M sold, first sale Mar 2014
No investor was named in the report.
From a historical funding recordSEC filing: $3.5M sold, first sale Mar 2014
No investor was named in the report.
From a historical funding recordSEC filing: $61K sold, first sale Apr 2010
No investor was named in the report.
Reported by sec.govSEC filing: $61K sold, first sale Apr 2010
No investor was named in the report.
From a historical funding recordSEC filing: $4.0M sold, first sale May 2009
No investor was named in the report.
From a historical funding recordSEC filing: $3.4M sold, first sale Apr 2009
From the SEC filings it signed: 3 on the team.
On the board, as filediAlfred D KingsleyAndrew C. von EschenbachFranklin M. BergerHenry L. NordhoffJudith D SegallNeal C BradsherPedro D LichtingerStephen C. Farrell
BioTime's investors include Juvenescence.
BioTime has raised $107M across 9 rounds since 2009.
BioTime's most recent round was an Undisclosed round of $43M in Aug 2018.
Its most recent round, $43M in Aug 2018, is also its largest on record.
BioTime's first round on record, in Aug 2018, was backed by Juvenescence.
BioTime's latest named round is an Undisclosed round, in Aug 2018.
BioTime is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.